Annual Drug Patent Expirations for CERDELGA
Cerdelga is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for CERDELGA.
This drug has one hundred and forty-one patent family members in forty-four countries.
The generic ingredient in CERDELGA is eliglustat tartrate. One supplier is listed for this compound. Additional details are available on the eliglustat tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
